“…Inspecting the correlation of protein expression, either with GPR19 up- or downregulation, at the highest level, a strong functional intersection between GPR19 activity and aging was apparent. Hence many of the most closely-correlated factors associated with GPR19 upregulation are tightly linked with metabolic aging (FASN: [ 165 ]; ACLY [ 166 ]; NAMPT [ 167 ]; CAB39L [ 168 ]), mitochondrial and antioxidant activities (H6PD [ 169 ]; DIXDC1 [ 170 ]), damage-related cell cycle alterations/cancer (FLCN [ 171 ]; TES [ 172 ]), alterations in unfolded protein management linked to metabolic imbalances (FKBP11 [ 173 ]) and oncogenesis (TMTC4 [ 174 ]), DNA damage (DDX21 [ 175 ], and body weight (STRBP [ 176 ]. Performing a similar investigation of the most closely associated factors in GPR19 downregulation paradigms associations with DNA damage/cell cycle control (AURKB [ 177 ]; TMPO [ 178 ]; ITGB3BP [ 179 ]), metabolic aging (CTSB [ 180 ]; GART [ 181 ]; PLPP3 [ 182 ]; FAM102A [ 183 ]), inflammation (FSCN1 [ 184 ]), mitochondrially associated autophagic activity (LAMP2 [ 185 ]), cell growth and oncogenesis (GSG2 [ 186 ]), and aging-related dementia (SMIM19 [ 187 ]) were observed.…”